financetom
Business
financetom
/
Business
/
Vulcan rejects Mexico's 'illegal expropriation' of its investments
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Vulcan rejects Mexico's 'illegal expropriation' of its investments
May 27, 2024 12:07 PM

MEXICO CITY (Reuters) - U.S. construction company Vulcan Materials on Monday rejected what it considers the "illegal expropriation" of its investments in Mexico and said it remains open to a negotiated solution with the Mexican government.

The company has been engaged in a years-long conflict with Mexico's government after officials ordered a halt to limestone quarrying at Vulcan's mining unit in the coastal state of Quintana Roo in 2022, alleging environmental damages by the company, which denies the accusations.

Mexican President Andres Manuel Lopez Obrador last week said that the site had not been expropriated, only closed, and that it would remain closed at least until he leaves office in October.

In a statement on Monday, Vulcan described the suspension of their operations as "authoritarian" and said it could not produce or sell materials "due to the arbitrary actions of the government of Mexico in order to force us to give up our important investments in the region."

Last year, Lopez Obrador laid out plans to offer 6.5 billion Mexican pesos ($391 million) to buy the land where Vulcan Materials operates and solve the dispute, but said the company did not want to sell the land.

"The truth is that at no time have we received a 'generous offer' to buy our property," Vulcan said on Monday.

"We were given an informal appraisal, without signatures and without details, that substantially undervalues our assets, including the limestone reserves of which we own under Mexican law, as well as the only deep draft port in the region."

($1 = 16.6440 Mexican pesos)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
ImmunityBio Q3 Net Loss Narrows, Revenue Rises
ImmunityBio Q3 Net Loss Narrows, Revenue Rises
Nov 12, 2024
09:05 AM EST, 11/12/2024 (MT Newswires) -- ImmunityBio ( IBRX ) reported Q3 net loss Tuesday of $0.14 per diluted share, narrower than the loss of $0.19 a year earlier. Two analysts polled by Capital IQ expected a loss of $0.18. Revenue for the quarter ended Sept. 30 was $6.1 million, up from around $82,000 a year earlier. Three analysts...
Nayax Swings to Q3 Net Income, Revenue Increases; 2024 Revenue Guidance Lowered
Nayax Swings to Q3 Net Income, Revenue Increases; 2024 Revenue Guidance Lowered
Nov 12, 2024
09:04 AM EST, 11/12/2024 (MT Newswires) -- Nayax ( NYAX ) reported Q3 net income Tuesday of $0.019 per share, swinging from a loss of $0.093 a year earlier. Three analysts polled by Capital IQ expected no earnings. Revenue for the quarter ended Sept. 30 was $83.0 million, up from $63.3 million a year earlier. Analysts surveyed by Capital IQ...
Netflix's ad-supported tier hits 70 million users
Netflix's ad-supported tier hits 70 million users
Nov 12, 2024
(Reuters) - Netflix ( NFLX ) said on Tuesday that its ad-supported tier now has 70 million monthly active users globally, nearly doubling the number reported earlier this year. The streaming giant is experiencing a faster rate of adoption for its ad-based plan, priced at $6.99 per month in the U.S., as customers seek more affordable options. Netflix ( NFLX...
MAG Silver's Q3 Net Income, Sales Rise
MAG Silver's Q3 Net Income, Sales Rise
Nov 12, 2024
09:01 AM EST, 11/12/2024 (MT Newswires) -- MAG Silver ( MAG ) reported Q3 net income Tuesday of $0.22 per share, up from $0.09 a year earlier. Four analysts polled by Capital IQ expected $0.22. Sales for the quarter ended Sept. 30 were $176.4 million, compared with $125 million a year earlier. A single analyst surveyed by Capital IQ expected...
Copyright 2023-2026 - www.financetom.com All Rights Reserved